918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study

作者：Yonina R. Murciano‐Goroff, Yasutoshi Kuboki, John H. Strickler, Kanwal Pratap Singh Raghav, Antoine Hollebecque, D.H. Lee, Sho Kitano, A. Landa Magdalena, M.T. Moskovitz, M.R. Sharma, M. Cecchini, Iwona Ługowska, Zachary R. Hunter, Michael C. Burns, Martha Blaney, R.R. Li, Athanasios Vasilopoulos, M. Li, Theodore S. Jennaro, Takako Eguchi Nakajima · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.08.1487 · 被引用次数：3 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Radiopharmaceutical Chemistry and Applications